Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Clinical trial NCT03391791 · TERMINATED
Trial details
- NCT number
- NCT03391791
- Sponsor
- Adaptimmune
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-28
- Primary completion
- 2018-07-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.